ePharmaSolutions Launches an Innovative Patient Recruitment Application for
CONSHOHOCKEN, Pa., Nov. 15, 2012
CONSHOHOCKEN, Pa., Nov. 15, 2012 /PRNewswire/ --ePharmaSolutions announces
the launch of PatientLive™, an innovative new patient recruitment application
for the new Windows 8 platform.
ePharmaSolutions, a leading clinical services and technology solutions
provider has developed a suite of applications that will help change the way
patients are recruited and triaged into clinical studies. The solution
includes a consumer and sponsor component that will provide pharmaceutical
companies and CROs with a better return on their recruitment investment while
providing patients with more information about clinical trials and improved
chances to enroll into studies for which they may qualify.
"This is really a game changing application for the pharmaceutical companies
and the patients who are interested in participating in research studies,"
stated Lance Converse, ePharmaSolutions' Founder and CEO. "We are providing
sponsors with ways to optimize their recruitment spend while offering patients
personalized, geo-targeted information about new medical therapies and
clinical trial opportunities using unique matching algorithms."
"ePharmaSolutions has been working closely with Microsoft on the development
of several clinical trial applications using SharePoint 2010, Azure and
Windows 8," stated Chad Brooks, Healthcare Partner Architect Evangelist for
Windows 8 at Microsoft. "When they came to us with this new idea for
improving the patient recruitment process we got involved immediately to offer
it as part of the new Windows 8 platform."
The PatientLive™ app will be an integrated component of a groundbreaking
initiative that ePharmaSolutions is spearheading to bring together more than a
dozen major pharmaceutical companies and CROs to "share" potential study
participants who disqualify for each other's studies – aptly named "Patient
Sharing."The Patient Sharing initiative will leverage the recruitment spend
from each of the participating sponsors by immediately presenting people who
are deemed ineligible for one study with other pertinent study opportunities
based on previous screening responses. Seeing as approximately 90% of people
will not qualify for the first study they express interest in, the benefit for
pharmaceutical companies to participate in the consortium is clear.
ePharmaSolutions is a leading provider of technology-based clinical services
that helps improve the way sites are selected, trained, activated and managed
to exceed enrollment goals. ePharmaSolutions won the 2009 Bio-IT World Award
for best clinical trial technology and has activated and trained more than
300,000 clinical researchers in 120 countries for the top 20 pharmaceutical
companies in the world. ePharmaSolutions is headquartered in Philadelphia
with offices in Slough, UK. For more information, visit
www.epharmasolutions.com or email firstname.lastname@example.org. Contact Lance
Contact: Lance Converse, CEO, +1-610-832-2100
Press spacebar to pause and continue. Press esc to stop.